Table II.
Platelet biomarkers in COVID-19 patients
| T1 | T2 | T3 | p | ||
|---|---|---|---|---|---|
| AA-induced max PA, % | all | 39 [30–54] | 37 [32–45] | 39 [35–46] | 0.824 |
| non-ICU | 31.5 [28.5–47.5] | 28 [25–41] | 35 [30.5–44] | ||
| ICU | 41 [33–56] | 38 [33] | 39 [35–46] | ||
| ADP 5-induced max PA, % | all | 44 [36–53] | 46 [40–51] | 43 [37–48] | 0.321 |
| non-ICU | 38 [32–46] | 38 [33–52] | 39.5 [35–43] | ||
| ICU | 48 [40–55] | 48 [42–50] | 43 [38–48] | ||
| ADP 20-induced max PA, % | all | 58 [45–65] | 60 [48–64] | 52 [47–58] | 0.290 |
| non-ICU | 48 [42–63] | 47 [41–64] | 50 [44–53.5] | ||
| ICU | 61 [54–65] | 61 [54–65] | 56 [47–59] | ||
| TRAP-induced max PA, % | all | 57.5 [46–76] | 60.5 [50–71] | 54 [48–60] | 0.497 |
| non-ICU | 51 [43–58] | 51 [43–58] | 46.5 [44–58.5] | ||
| ICU | 66 [47–78] | 62 [54–71] | 56 [51–64] | ||
| P-selectin, (ng/ml) | all | 74 [50–113] | 69.6 [40.5–104.1] | 63.2 [39.8–87.7] | 0.044 |
| non-ICU | 50.1 [37.8–78.8] | 52.6 [31.2–68.4] | 37.9 [26.8–80.4] | ||
| ICU | 81.2 [55.2–134.9] | 78.8 [58.1–122.8] | 65.8 [45.1–92.1] | ||
| sCD40L, (pg/ml) | all | 398 [167–859.6] | 340.6 [76.1–642.8] | 164.1 [79.7–556.9] | 0.039 |
| non-ICU | 231.1 [97.4–415.5] | 65.9 [23.4–208.1] | 72.9 [46.3–164] | ||
| ICU | 432.4 [264.9–1008.5] | 463.1 [108.8–1028.9] | 192.3 [87.8–756.9] |
The values are reported as median and interquartile range. The p-value is for the trend from T1 to T3.
ICU: intensive care unit. AA: arachidonic acid. ADP: adenosine diphosphate. TRAP: thrombin receptor agonist peptide. sCD40L: soluble CD40 ligand.